Neuroinflammation and oxidative stress in diabetic neuropathy: Futuristic strategies based on these targets

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Sandireddy, Reddemma ^a   Yerra, Veera Ganesh ^a   Areti, Aparna ^a   Komirishetty, Prashanth ^a   Kumar, Ashutosh ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYLBUTYRIC ACID; ALPHA TOCOPHEROL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIOXIDANT; CHAPERONE; ENDOTHELIN B RECEPTOR ANTAGONIST; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEVACECARNINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXYNITRITE; THIOCTIC ACID; TRANSCRIPTION FACTOR NRF2; TRIMETHYLAMINE OXIDE;

BLOOD VESSEL INJURY; CONFOCAL MICROSCOPY; CORNEA; CORNEAL CONFOCAL MICROSCOPY; DIABETIC NEUROPATHY; HUMAN; HYPERGLYCEMIA; MITOCHONDRIAL TOXICITY; NERVE FIBER; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PERCEPTIVE THRESHOLD; PERIPHERAL NERVE INJURY; REVIEW; SKIN BIOPSY; VIBRATION PERCEPTION THRESHOLD; VIBRATION SENSE;

EID: 84901044521     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/674987     Document Type: Review

References (84)

1. IDF Diabetes Atlas 2013 6th International Diabetes Federation
2. IDF Diabetes Atlas 2012 5th International Diabetes Federation
3. Huizinga M. M., Peltier A., Painful diabetic neuropathy: a management-centered review. Clinical Diabetes 2007 25 1 6 15 2-s2.0-33846974022 10.2337/diaclin.25.1.6
4. Vinik A. I., Mehrabyan A., Diabetic neuropathies. Medical Clinics of North America 2004 88 4 947 999 2-s2.0-4143077217 10.1016/j.mcna.2004.04.009 (Pubitemid 39090347)
5. Oates P. J., Aldose reductase, still a compelling target for diabetic neuropathy. Current Drug Targets 2008 9 1 14 36 2-s2.0-38849177363 10.2174/138945008783431781 (Pubitemid 351201678)
6. Schmid U., Stopper H., Heidland A., Schupp N., Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro. Diabetes/Metabolism Research and Reviews 2008 24 5 371 377 2-s2.0-46349083981 10.1002/dmrr.860
7. Du X.-L., Edelstein D., Rossetti L., Fantus I. G., Goldberg H., Ziyadeh F., Wu J., Brownlee M., Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proceedings of the National Academy of Sciences of the United States of America 2000 97 22 12222 12226 2-s2.0-0034710891 10.1073/pnas.97.22.12222
8. Purves T., Middlemas A., Agthong S., Jude E. B., Boulton A. J. M., Fernyhough P., Tomlinson D. R., A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. The FASEB Journal 2001 15 13 2508 2514 2-s2.0-0035158585 10.1096/fj.01-0253hyp (Pubitemid 33063180)
9. Forbes J. M., Cooper M. E., Mechanisms of diabetic complications. Physiological Reviews 2013 93 137 188
10. Negi G., Kumar A., Kaundal R. K., Gulati A., Sharma S. S., Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy. Neuropharmacology 2010 58 3 585 592 2-s2.0-73449142425 10.1016/j.neuropharm.2009.11.018
11. Pop-Busui R., Marinescu V., van Huysen C., Li F., Sullivan K., Greene D. A., Larkin D., Stevens M. J., Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration. Diabetes 2002 51 8 2619 2628 2-s2.0-0036323283 (Pubitemid 34827415)
12. Ekberg K., Johansson B.-L., Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetes. Experimental Diabetes Research 2008 2008 457912 10.1155/2008/457912 2-s2.0-42449127541
13. Singh R., Kishore L., Kaur N., Diabetic peripheral neuropathy: current perspective and future directions. Pharmacological Research 2014 80 21 35
14. Duby J. J., Campbell R. K., Setter S. M., White J. R., Rasmussen K. A., Diabetic neuropathy: an intensive review. American Journal of Health-System Pharmacy 2004 61 2 160 176 2-s2.0-1842592020 (Pubitemid 39004640)
15. Jensen T. S., Backonja M.-M., Hernández Jiménez S., Tesfaye S., Valensi P., Ziegler D., New perspectives on the management of diabetic peripheral neuropathic pain. Diabetes and Vascular Disease Research 2006 3 2 108 119 2-s2.0-33750396100 10.3132/dvdr.2006.013 (Pubitemid 44638385)
16. Ziegler D., Painful diabetic neuropathy: treatment and future aspects. Diabetes/Metabolism Research and Reviews 2008 24 1 S52 S57 2-s2.0-44949256456 10.1002/dmrr.817 (Pubitemid 351802772)
17. Brownlee M., Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 6865 813 820 2-s2.0-0035856980 10.1038/414813a (Pubitemid 34000785)
18. Chung S. S. M., Ho E. C. M., Lam K. S. L., Chung S. K., Contribution of polyol pathway to diabetes-induced oxidative stress. Journal of the American Society of Nephrology 2003 14 3 S233 S236 2-s2.0-0042867413 (Pubitemid 36903931)
19. Cameron N. E., Cotter M. A., Jack A. M., Basso M. D., Hohman T. C., Protein kinase C effects on nerve function, perfusion, Na+,K+-ATPase activity and glutathione content in diabetic rats. Diabetologia 1999 42 9 1120 1130 2-s2.0-0032842640 10.1007/s001250051280 (Pubitemid 29408811)
20. Koya D., King G. L., Protein kinase C activation and the development of diabetic complications. Diabetes 1998 47 6 859 866 2-s2.0-0031860340 10.2337/diabetes.47.6.859 (Pubitemid 28255657)
21. Lee H. B., Yu M. R., Song J. S., Ha H., Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney International 2004 65 4 1170 1179 2-s2.0-1642463525 10.1111/j.1523-1755.2004.00491.x (Pubitemid 38406955)
22. Brownlee M., The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005 54 6 1615 1625 2-s2.0-20044376702 10.2337/diabetes.54. 6.1615 (Pubitemid 40770750)
23. Hirata K.-I., Kuroda R., Sakoda T., Katayama M., Inoue N., Suematsu M., Kawashima S., Yokoyama M., Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension 1995 25 2 180 185 2-s2.0-0028798319
24. King R. H. M., The role of glycation in the pathogenesis of diabetic polyneuropathy. Molecular Pathology 2001 54 6 400 408 2-s2.0-0035662674 (Pubitemid 34025255)
25. Takeuchi M., Takino J.-I., Yamagishi S.-I., Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy. Current Drug Targets 2010 11 11 1468 1482 2-s2.0-79954991400
26. Bardini G., Rotella C. M., Giannini S., Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro-and macrovascular complications. The Review of Diabetic Studies 2011 9 82 93
27. Kolm-Litty V., Sauer U., Nerlich A., Lehmann R., Schleicher E. D., High glucose-induced transforming growth factor β 1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. Journal of Clinical Investigation 1998 101 1 160 169 2-s2.0-0031975643 (Pubitemid 28058915)
28. Chen Y.-Q., Su M., Walia R. R., Hao Q., Covington J. W., Vaughan D. E., Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells. Journal of Biological Chemistry 1998 273 14 8225 8231 2-s2.0-0032478827 10.1074/jbc.273.14.8225 (Pubitemid 28168879)
29. Giacco F., Brownlee M., Oxidative stress and diabetic complications. Circulation Research 2010 107 9 1058 1070 2-s2.0-78349297565 10.1161/CIRCRESAHA.110.223545
30. Rodacka A., Serafin E., Puchala M., Efficiency of superoxide anions in the inactivation of selected dehydrogenases. Radiation Physics and Chemistry 2010 79 9 960 965 2-s2.0-77953359137 10.1016/j.radphyschem.2010.04.001
31. Du X., Matsumura T., Edelstein D., Rossetti L., Zsengellér Z., Szabó C., Brownlee M., Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. Journal of Clinical Investigation 2003 112 7 1049 1057 2-s2.0-0242285699 10.1172/JCI200318127 (Pubitemid 38056320)
32. Shen X., Zheng S., Metreveli N. S., Epstein P. N., Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. Diabetes 2006 55 3 798 805 2-s2.0-33644766038 10.1562/2005-10-20-RN-723
33. Rolo A. P., Palmeira C. M., Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicology and Applied Pharmacology 2006 212 2 167 178 2-s2.0-33645765312 10.1016/j.taap.2006.01.003
34. Fernyhough P., Huang T.-J., Verkhratsky A., Mechanism of mitochondrial dysfunction in diabetic sensory neuropathy. Journal of the Peripheral Nervous System 2003 8 4 227 235 2-s2.0-0346724201 10.1111/j.1085-9489.2003.03028.x (Pubitemid 37553738)
35. Srinivasan S., Stevens M., Wiley J. W., Diabetic peripheral neuropathy: evidence for apoptosis associated mitochondrial dysfunction. Diabetes 2000 49 11 1932 1938 2-s2.0-0033760829
36. Vincent A. M., Edwards J. L., McLean L. L., Hong Y., Cerri F., Lopez I., Quattrini A., Feldman E. L., Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy. Acta Neuropathologica 2010 120 4 477 489 2-s2.0-77956186984 10.1007/s00401-010-0697-7
37. Sajic M., Mitochondrial dynamics in peripheral neuropathies. Antioxidants & Redox Signaling 2014 10.1089/ars.2013.5822
38. Yan S. D., Schmidt A. M., Anderson G. M., Zhang J., Brett J., Zou Y. S., Pinsky D., Stern D., Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. Journal of Biological Chemistry 1994 269 13 9889 9897 2-s2.0-0028304625 (Pubitemid 24196599)
39. Wada R., Yagihashi S., Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Annals of the New York Academy of Sciences 2005 1043 598 604 2-s2.0-23744467294 10.1196/annals.1338.067 (Pubitemid 41123949)
40. Vlassara H., Cai W., Crandall J., Goldberg T., Oberstein R., Dardaine V., Peppa M., Rayfield E. J., Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proceedings of the National Academy of Sciences of the United States of America 2002 99 24 15596 15601 2-s2.0-0037180567 10.1073/pnas.242407999 (Pubitemid 35403978)
41. Ganesh Yerra V., Negi G., Sharma S. S., Kumar A., Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF- κ B pathways in diabetic neuropathy. Redox Biology 2013 1 394 397
42. Shi X., Chen Y., Nadeem L., Xu G., Beneficial effect of TNF- α inhibition on diabetic peripheral neuropathy. Journal of Neuroinflammation 2013 10, article 69 10.1186/1742-2094-10-69
43. Wang X.-M., Lehky T. J., Brell J. M., Dorsey S. G., Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy. Cytokine 2012 59 1 3 9 2-s2.0-84859930034 10.1016/j.cyto.2012.03.027
44. Ramesh G., MacLean A. G., Philipp M. T., Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators of Inflammation 2013 2013 20 480739 10.1155/2013/480739
45. Soskić S. S., Dobutović B. D., Sudar E. M., Obradović M. M., Nikolić D. M., Radak D. J., Mikhailidis D. P., Isenović E. R., Regulation of inducible Nitric Oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure. Open Cardiovascular Medicine Journal 2011 5 1 153 163 2-s2.0-80053525165 10.2174/1874192401105010153
46. Maccarrone M., Brüne B., Redox regulation in acute and chronic inflammation. Cell Death and Differentiation 2009 16 8 1184 1186 2-s2.0-67650763693 10.1038/cdd.2009.65
47. Pacher P., Beckman J. S., Liaudet L., Nitric oxide and peroxynitrite in health and disease. Physiological Reviews 2007 87 1 315 424 2-s2.0-33846863589 10.1152/physrev.00029.2006 (Pubitemid 46217686)
48. Szabó C., Multiple pathways of peroxynitrite cytotoxicity. Toxicology Letters 2003 140-141 105 112 2-s2.0-0037432615 10.1016/S0378-4274(02) 00507-6 (Pubitemid 36378928)
49. Wakabayashi N., Slocum S. L., Skoko J. J., Shin S., Kensler T. W., When NRF2 talks, who's listening? Antioxidants and Redox Signaling 2010 13 11 1649 1663 2-s2.0-77956915802 10.1089/ars.2010.3216
50. Tan Y., Ichikawa T., Li J., Si Q., Yang H., Chen X., Goldblatt C. S., Meyer C. J., Li X., Cai L., Cui T., Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes 2011 60 2 625 633 2-s2.0-79551575483 10.2337/db10-1164
51. Poli G., Leonarduzzi G., Biasi F., Chiarpotto E., Oxidative stress and cell signalling. Current Medicinal Chemistry 2004 11 9 1163 1182 2-s2.0-2342629352 (Pubitemid 38585060)
52. Cameron N. E., Cotter M. A., Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway. Current Drug Targets 2008 9 1 60 67 2-s2.0-38949112858 10.2174/138945008783431718 (Pubitemid 351209290)
53. Karin M., The regulation of AP-1 activity by mitogen-activated protein kinases. Journal of Biological Chemistry 1995 270 28 16483 16486 2-s2.0-0029032249
54. Liu G.-H., Qu J., Shen X., NF- B/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochimica et Biophysica Acta-Molecular Cell Research 2008 1783 5 713 727 2-s2.0-41949141296 10.1016/j.bbamcr.2008.01.002
55. Scholz J., Woolf C. J., The neuropathic pain triad: neurons, immune cells and glia. Nature Neuroscience 2007 10 11 1361 1368 2-s2.0-35548937457 10.1038/nn1992 (Pubitemid 350014681)
56. Myers R. R., Campana W. M., Shubayev V. I., The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discovery Today 2006 11 1-2 8 20 2-s2.0-32444451323 10.1016/S1359-6446(05)03637-8 (Pubitemid 43227847)
57. Veves A., Diagnosis of diabetic neuropathy. Clinical Management of Diabetic Neuropathy 1998 7 Springer 61 75
58. Malik R. A., Kallinikos P., Abbott C. A., Van Schie C. H. M., Morgan P., Efron N., Boulton A. J. M., Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia 2003 46 5 683 688 2-s2.0-0038353187 (Pubitemid 36808188)
59. Polydefkis M., Hauer P., Griffin J. W., McArthur J. C., Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy. Diabetes Technology and Therapeutics 2001 3 1 23 28 2-s2.0-0035031043 10.1089/152091501750219994 (Pubitemid 32405674)
60. Farmer K. L., Li C., Dobrowsky R. T., Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach? Pharmacological Reviews 2012 64 880 900
61. Lupachyk S., Watcho P., Stavniichuk R., Shevalye H., Obrosova I. G., Endoplasmic reticulum stress plays a key role in the pathogenesis of diabetic peripheral neuropathy. Diabetes 2013 62 944 952
62. Pacher P., Obrosova I. G., Mabley J. G., Szabó C., Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Current Medicinal Chemistry 2005 12 3 267 275 2-s2.0-14544297961 (Pubitemid 40305619)
63. Obrosova I. G., Mabley J. G., Zsengellér Z., Charniauskaya T., Abatan O. I., Groves J. T., Szabó C., Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst. The FASEB Journal 2005 19 3 401 403 2-s2.0-14644405532 10.1096/fj.04-1913fje (Pubitemid 40316530)
64. Obrosova I. G., Drel V. R., Pacher P., Ilnytska O., Wang Z. Q., Stevens M. J., Yorek M. A., Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes 2005 54 12 3435 3441 2-s2.0-33644681565 10.2337/diabetes.54. 12.3435 (Pubitemid 43334333)
65. Ziegler D., Hanefeld M., Ruhnau K.-J., Hasche H., Lobisch M., Schütte K., Kerum G., Malessa R., Treatment of symptomatic diabetic polyneuropathy with the antioxidant α -lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III study). Diabetes Care 1999 22 8 1296 1301 2-s2.0-0032788081 10.2337/diacare.22.8.1296 (Pubitemid 29350240)
66. Sima A. A. F., Calvani M., Mehra M., Amato A., Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care 2005 28 1 89 94 2-s2.0-11844273799 10.2337/diacare.28.1.89 (Pubitemid 40095788)
67. Tütüncü N. B., Bayraktar M., Varli K., Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary study. Diabetes Care 1998 21 11 1915 1918 2-s2.0-0031723579 10.2337/diacare.21.11.1915 (Pubitemid 28478293)
68. Vallianou N., Evangelopoulos A., Koutalas P., Alpha-lipoic acid and diabetic neuropathy. Review of Diabetic Studies 2009 6 4 230 236 2-s2.0-75749135680 10.1900/RDS.2009.6.230
69. Cameron N. E., Cotter M. A., Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Research and Clinical Practice 1999 45 2-3 137 146 2-s2.0-0032836681 10.1016/S0168-8227(99)00043-1 (Pubitemid 29457761)
70. Maxfield E. K., Love A., Cotter M. A., Cameron N. E., Nerve function and regeneration in diabetic rats: effects of ZD-7155, an AT1 receptor antagonist. American Journal of Physiology-Endocrinology and Metabolism 1995 269 3 E530 E537 2-s2.0-0028891081
71. Cameron N. E., Dines K. C., Cotter M. A., The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats. Diabetologia 1994 37 12 1209 1215 2-s2.0-0027960510 10.1007/s001250050237 (Pubitemid 24356760)
72. Aydin A., Özden B. Ç., Karamürsel S., Solakolu S., Aktaş Ş., Erer M., Effect of hyperbaric oxygen therapy on nerve regeneration in early diabetes. Microsurgery 2004 24 3 255 261 2-s2.0-2642549081 10.1002/micr.20038 (Pubitemid 38720809)
73. Kellogg A. P., Wiggin T. D., Larkin D. D., Hayes J. M., Stevens M. J., Pop-Busui R., Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes. Diabetes 2007 56 12 2997 3005 2-s2.0-36849058141 10.2337/db07-0740 (Pubitemid 350223635)
74. Kumar A., Sharma S. S., NF- B inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy. Biochemical and Biophysical Research Communications 2010 394 2 360 365 2-s2.0-77950189559 10.1016/j.bbrc.2010.03.014
75. Kumar A., Negi G., Sharma S. S., Suppression of NF- B and NF- B regulated oxidative stress and neuroinflammation by BAY 11-7082 (I B phosphorylation inhibitor) in experimental diabetic neuropathy. Biochimie 2012 94 5 1158 1165 2-s2.0-84859419837 10.1016/j.biochi.2012.01.023
76. Kumar A., Negi G., Sharma S. S., JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence. Diabetes, Obesity and Metabolism 2011 13 8 750 758 2-s2.0-79959441139 10.1111/j.1463-1326.2011.01402.x
77. Negi G., Kumar A., Sharma S. S., Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF- B and Nrf2 cascades. Journal of Pineal Research 2011 50 2 124 131 2-s2.0-79951642115 10.1111/j.1600-079X.2010.00821.x
78. Negi G., Kumar A., Sharma S. S., Nrf2 and NF- B modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes. Current Neurovascular Research 2011 8 4 294 304 2-s2.0-82155197554 10.2174/156720211798120972
79. Kamboj S. S., Vasishta R. K., Sandhir R., N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy. Journal of Neurochemistry 2010 112 1 77 91 2-s2.0-71649086882 10.1111/j.1471-4159.2009.06435.x
80. Smith R. A. J., Murphy M. P., Mitochondria-targeted antioxidants as therapies. Discovery medicine 2011 11 57 106 114 2-s2.0-79957764437
81. Szeto H. H., Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. The AAPS Journal 2006 8 3 521 531 2-s2.0-33748201552 10.1208/aapsj080362 (Pubitemid 44313412)
82. Chacko B. K., Reily C., Srivastava A., Johnson M. S., Ye Y., Ulasova E., Agarwal A., Zinn K. R., Murphy M. P., Kalyanaraman B., Darley-Usmar V., Prevention of diabetic nephropathy in Ins2+/-AkitaJ mice by the mitochondria-targeted therapy MitoQ. Biochemical Journal 2010 432 1 9 19 2-s2.0-78649755150 10.1042/BJ20100308
83. Choi J., Chandrasekaran K., Inoue T., Muragundla A., Russell J. W., PGC-1 α regulation of mitochondrial degeneration in experimental diabetic neuropathy. Neurobiology of Disease 2014 64 118 130
84. Valle I., Álvarez-Barrientos A., Arza E., Lamas S., Monsalve M., PGC-1 α regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovascular Research 2005 66 3 562 573 2-s2.0-19444365211 10.1016/j.cardiores.2005.01.026 (Pubitemid 40725768)